The nontreatment of childhood ITP (or "The art of medicine consists of amusing the patient until nature cures the disease")

Seminars in Thrombosis and Hemostasis

Volumn 27, Issue 3, 2001, Pages 269-275

  Bolton Maggs, P H B ^a   Dickerhoff, R ^a   Vora, A J ^a  

^a ALDER HEY CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

Children; Drug toxicity; Expectant approach; Idiopathic thrombocytopenic purpura; Platelet count

Indexed keywords

ADOLESCENT; CHILD; CHILDHOOD DISEASE; CONFERENCE PAPER; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DISEASE SEVERITY; EUROPE; FEMALE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INFANT; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; PATIENT EDUCATION; PRIORITY JOURNAL; QUALITY OF LIFE; THROMBOCYTE COUNT; TREATMENT PLANNING;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DECISION MAKING; HUMANS; INFANT; PARENTS; PLATELET COUNT; PRACTICE GUIDELINES; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; WITHHOLDING TREATMENT;

EID: 0034976270     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-15256     Document Type: Conference Paper

References (33)

1. Idiopathic thrombocytopenia in childhood. Edinburgh experience 1962-82
2. Idiopathic thrombocytopenic purpura in childhood
3. Idiopathic thrombocytopenic purpura in childhood
4. Idiopathic thrombocytopenic purpura - To treat or not to treat?
5. The nontreatment of childhood idiopathic thrombocytopenic purpura
6. Current controversies in the management of idiopathic thrombocytopenic purpura during childhood
7. Acute idiopathic thrombocytopenic purpura - Management in childhood
8. Assessment of UK practice for management of acute childhood idiopathic thrombocytopenic purpura against published guidelines
9. Acute idiopathic thrombocytopenic purpura - Management in childhood
10. Chronic idiopathic thrombocytopenic purpura: Primum non nocere
11. Idiopathic thrombocytopenic purpura: Reasons to resolve the chaos
12. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood
13. Intravenous immunoglobulin versus oral corticosteroids in acute immune thrombocytopenic purpura in childhood
14. Side effects of intravenous immunoglobulins
15. Neurologic complications of treatment of childhood acute immune thrombocytopenic purpura with intravenously administered immunoglobulin G
16. Guidelines for management of idiopathic thrombocytopenic purpura
17. Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura
18. Intracranial haemorrhage in idiopathic thrombocytopenic purpura. Paediatric Haematology Forum of the British Society for Haematology
19. Intracranial hemorrhage in chronic childhood ITP
20. Idiopathic thrombocytopenic purpura: A practice guideline developed by explicit methods for the American Society of Hematology
21. Investigation and treatment of immune thrombocytopenic purpura in children in Norway
22. Akute postinfectiöse immunthrombozytopenie (ITP) im kindesalter
23. Quantitative and qualitative platelet disorders
24. Platelet counting and the assessment of platelet function
25. Enumeration of platelets by multiparameter flow cytometry using platelet-specific anti-bodies and fluorescent reference particles
26. Acute immune thrombocytopenia in childhood. Are we treating the platelet count?
27. Expectant management of childhood immune thrombocytopenic purpura
28. The clinical course of immune thrombocytopenic purpura in children who did not receive intravenous immunoglobulin or sustained prednisone treatment
29. The management of ITP - Few need active therapy. An 8 year review of consecutive unselected cases
30. Psychosocial impact of chronic idiopathic thrombocytopenic purpura: A parent's view
31. A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura
32. Management of childhood idiopathic thrombocytopenic purpura
33. Corticosteroid prophylaxis for neurologic complications of intravenous immunoglobulin G therapy in childhood immune thrombocytopenic purpura